Text/HTML

RELIFE.
MY SKIN SAYS
HOW I FEEL.

CONSCIOUS INNOVATION IN WELL-BEING.


RELIFE is a long-lasting project that counts on the close collaboration with the leading Healthcare Professionals all around the globe, to develop a brand-new way in skin treatments.

RELIFE is focused on the recovery of the purest essence of a person, pursuing a healthy and good looking skin knowing that it is the mirror of the inner well-being of a person. This is why at RELIFE we talk about conscious innovation: premium scientific based innovation at the service of our consumers.

TIME FOR
A NEW WAY.


RELIFE is an ambitious and innovative project that aims at promoting a revolutionary way to approach the Dermatology and Medical Aesthetics markets.

This new company will lay its foundations on the scientific heritage and high quality standards of the Menarini Group, which was established in Italy in 1886 and is the leading Italian pharmaceutical Company in the world.

RELIFE IS THE NEW WORLDWIDE
COMPANY THAT FINDS ITS ROOTS
IN THE MENARINI GROUP.

HIGH QUALITY
YOU CAN TRUST.


From development and manufacturing to scientific information.
  • Work with health care professionals to bring conscious innovation to the patients
  • Partner with the scientific community to develop and deliver continuous medical education
  • Patients-centered care and science-based approach in everything we do
  • Listen to the needs of the patients and Healthcare Professionals to provide the best in class added value services

DERMATOLOGY


RELIFE will cure each specific skin condition by providing men, women, and children with effective and highly innovative complete premium product ranges.

AESTHETIC
MEDICINE


RELIFE will offer Healthcare Professionals a holistic approach to Aesthetic Medicine. A natural looking appearance thanks to a combination of unique techniques.

MENARINI GROUP.
PRESENT IN MORE THAN
100 COUNTRIES WORLDWIDE.

GLOBALLY
CLOSE TO YOU.


The Menarini Group, with its headquarters in Florence, is present in 136 countries around the world with 17,000 employees. With a turnover of 3.6 billion Euro, Menarini today is 13th in Europe out of 5.345 companies and 35th worldwide out of 21,587 (source: IQVIA). Menarini has 6 Research & Development centres and its products are present in the most important therapeutic areas including cardiology, gastroenterology, pneumology, infectious diseases, diabetology, anti-inflammatory agents, and analgesics.

Menarini’s products are manufactured in the Group's 16 production sites, in Italy and abroad, where more than 583 million packs are produced and distributed over five continents each year. Through its pharmaceutical products, Menarini contributes continuously and with the highest quality standards towards the health of patients all around the world.